Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review.

MLA

Petrie, John L., et al. “Real-World Persistence with Ocrelizumab in Multiple Sclerosis: A Systematic Review.” Neurology & Therapy, vol. 13, no. 6, Dec. 2024, pp. 1597–605. EBSCOhost, https://doi.org/10.1007/s40120-024-00667-w.

APA

Petrie, J. L., Smith, C. A., Fountain, D., & Machnicki, G. (2024). Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review. Neurology & Therapy, 13(6), 1597–1605. https://doi.org/10.1007/s40120-024-00667-w

Chicago

Petrie, John L., Charlie A. Smith, Donna Fountain, and Gerardo Machnicki. 2024. “Real-World Persistence with Ocrelizumab in Multiple Sclerosis: A Systematic Review.” Neurology & Therapy 13 (6): 1597–1605. doi:10.1007/s40120-024-00667-w.